Tag: HIV/AIDS

Zimbabwe is the first country in Africa to announce regulatory approval for long-acting injectable cabotegravir for HIV prevention

The Medicines Control Authority of Zimbabwe (MCAZ) announced that it has approved the use of long-acting injectable cabotegravir (CAB-LA) as pre-exposure prophylaxis (PrEP) for HIV prevention. “The information submitted to support the approval of the product indicated that the product is safe, effective and of good quality. MCAZ is confident that the product will benefit […]...

WHO recommends long-lasting cabotegravir for HIV prevention

News Release by World Health Organization WHO on 28/07/22 released new guidelines for the use of long-acting injectable cabotegravir (CAB-LA) as pre-exposure prophylaxis (PrEP) for HIV and calle...

4 Dec 2020

World AIDS Day- Impact of COVID-19 on ending the HIV/AIDS epidemic

It is nearly 40 years since the first reported case of HIV/AIDS. The 32nd edition of the World AIDS Day was commemorated under an unprecedented norm occasioned by the COVID-19 pandemic. Over and above...

Tag: HIV/AIDS

Zimbabwe is the first country in Africa to announce regulatory approval for long-acting injectable cabotegravir for HIV prevention

More on Tag: HIV/AIDS

WHO recommends long-lasting cabotegravir for HIV prevention

World AIDS Day- Impact of COVID-19 on ending the HIV/AIDS epidemic